Discovery and Characterization of Cas9 Inhibitors Disseminated across Seven Bacterial PhylaRuben Vazquez-Uribe(Novo Nordisk Foundation), Morten Otto Alexander Sommer(Novo Nordisk Foundation)Cell Host & MicrobeFebruary 1, 201910.1016/j.chom.2019.01.003Cited by 84SaveCiteExport RISWatch citationsRelated PapersTopical niclosamide (ATx201) reduces <i>Staphylococcus aureus</i> colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trial|Clinical and Translational Medicine|2022|46